Stanford University: Lung disease and antibody levels contribute to long COVID, Stanford researchers find
People recovering from COVID-19 with a history of lung disease, including asthma or chronic obstructive pulmonary disorder, or who had lower levels of a particular antibody in the first week of diagnosis, took longer than their peers to experience a
Source: indiaeducationdiary.in
